Huiqiang Huang

2PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis.

Jing Yang, Qiu-Zi Zhong, Li-Ting Qian

|Mar 30, 2023
Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study.

Huiqiang Huang, Rong Tao, Siguo Hao

Pageof 1

Frequent Collaborators

1 joint publications

Qiu-Zi Zhong

1 joint publications

Yong Yang

1 joint publications

Xiao-Rong Hou

1 joint publications

Xi-Mei Zhang